Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 February 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
Prof Angelique van Niekerk and CP Naude
Charl-Pierre Naudé with Prof Angelique van Niekerk after launch and discussion of his book.

Die Ongelooflike Onskuld van Dirkie Verwey is the debut novel by Charl-Pierre Naudé, research fellow in the Department of Afrikaans and Dutch, German and French at the University of the Free State (UFS).

Naudé has published four volumes of poetry and is a poet by profession. Die Ongelooflike Onskuld van Dirkie Verwey is his first leap from poetry to prose. He is also a former winner of the Ingrid Jonker Prize for poetry.

The book, published by Tafelberg, was launched on the UFS Bloemfontein Campus on Thursday 30 January 2019 where Naudé was in conversation with Dr Francois Smit, also from the Department of Afrikaans and Dutch, German and French, during which the two of them attempted to analyse the world of the main characters; however, Naudé did not want to give away too much. ”I think people should read the book,” he said.

Spiritual and physical worlds

 

“The novel is a first-person narrative told by one of the characters. I wanted to play a certain bluff to determine exactly who the author of this book was,” said Naudé. The book is not totally explicable. “I wanted the reader to feel that it is not absolutely true.”

''The book seeks to combine the spiritual and physical worlds,” said Naudé. Die Ongelooflike Onskuld van Dirkie Verwey is essentially a love story in which the two worlds merge, but nonetheless never mix.

 

Creative writing course revived

 

“The book is Charl-Pierre’s creative output which forms part of his creative writing course,” said Head of Department, Prof Angelique van Niekerk. This is the first book published after the revival of the creative writing course at the UFS in 2015 – and what a book to kick off with!

“It is of great importance for our department to have been part of this book,” Dr Smith said.

Read here the article published in Huisgenoot.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept